NL-OMON20017暂停不适用
An Open Label Trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade®) in the Treatment of Endogenous Uveitis or Vasculitis unresponsive to Standard Therapy.
AMC Medical Research B.V., Prof. Dr. M.D. de Smet, Meibergdreef 9, 1105 AZ AMSTERDAM ZO, The Netherlands, +31 20 566 34 590 个研究点目标入组 49 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 暂停
- 发起方
- 入组人数
- 49
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Men or women 18 years of age with non-infectious bilateral sight-threatening uveitis due to one of the inflammatory conditions listed below:
- •a. Ocular sarcoidosis;
排除标准
- •1. Inability to visualize the fundus due to corneal or lenticular opacities;
- •2. Patients requiring ocular surgery within the initial 3 months of treatment, or who have had surgery in the prior 3 months;
研究者
相似试验
已完成
不适用
A non-controlled trial of Anti-TNFa Chimeric Monoclonal Antibody (Infliximab, Remicade®) in Exudative Age Related Macular Degeneration.Exudative Age Related Macular Degeneration.Exudatieve leeftijdgebonden Macula DegeneratieNL-OMON20009Erasmus Medisch CentrumDr. Molewaterplein 403015 GD Rotterdam&Oogziekenhuis RotterdamSchiedamse Vest 1803011 BH Rotterdam40
进行中（未招募）
1 期
A Prospective Trial of Anti-TNF-a Chimeric Monoclonal Antibody (infliximab, Remicade®) on Insulin Sensitivity, Beta Cell Function and Cardiovascular Risk Profile in Insulin Resistant Human ObesityEUCTR2005-000181-39-ATMed. Universitaetsklinik Graz, ao Univ. Professor Dr. med. Thomas C. Wascher18
已完成
不适用
A placebo-controlled trial of anti-TNFa chimeric monoclonal antibody (infliximab, remicade) in the modification of vascular disease markers in active rheumatoid arthritisMusculoskeletal DiseasesRheumatoid ArthritisISRCTN29665463Guy's & St Thomas' NHS Foundation Trust (UK)30
已完成
3 期
An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's DiseaseCrohn DiseaseNCT00269841Centocor, Inc.94
已完成
不适用
ltrasound Guided Synovial Biopsy to determine treatment response to Rituxumab versus TocilizumabTopic: MusculoskeletalSubtopic: Musculoskeletal (all Subtopics)Disease: Inflammatory ArthritisMusculoskeletal DiseasesRheumatoid arthritis, unspecifiedISRCTN97443826Queen Mary University of London (UK)164